The largest community of pharma leaders

Michael Lee-Chin joins the ITM Supervisory Board

GARCHING, Germany–(BUSINESS WIRE)–#NETcancer–ITM Isotopen Technologien München AG (ITM), a radiopharmaceutical group of companies, announced today the appointment of Michael Lee-Chin to its supervisory board, starting May 23, 2019. Mr. Lee-Chin is founder and chairman of Portland Holdings, a privately held investment company headquartered in Burlington, Ontario, Canada. Portland Holdings is committed to investing in businesses active in strong, long-term growth industries that also seek to improve the…

Recent Articles